Insight Molecular Diagnostics Inc (IMDX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Insight Molecular Diagnostics Inc   (NASDAQ: IMDX)


Insight Molecular Diagnostics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Insight Molecular Diagnostics Inc's ROI in the second quarter of 2026?
Insight Molecular Diagnostics Inc recorded a cumulative net loss of $-49 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -192.47%.

Within the Healthcare sector 16 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3270 to 4054.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -44.09 % -38.55 % -31.75 % -31.69 % -24.57 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 19 28 19 36 44
Return On Investment (TTM) -192.47 % -150.34 % -134.34 % -176.78 % -158.59 %
IMDX's Overall Ranking # 4054 # 3270 # 3885 # 2849 #
Seq. Investment Change TTM -19.41 % -14.88 % -5.73 % -13.54 % -11.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -49 -48 -50 -70 -73

IMDX Company Profile >> Back to IMDX Roi Comparisons >> See Annual IMDX Return On Investment



Return On Investment IMDX's Ranking
Within: No.
Industry # 0
Sector # 17
Overall # 4054

Return On Investment Statistics
High Average Low
-17.89 %
-75.88 %
-176.78 %
(Mar 31 2024)   (Sep 30 2025)







Financial Statements
Insight Molecular Diagnostics Inc's II. Quarter Investments $ 19 Millions IMDX's Balance sheet
Insight Molecular Diagnostics Inc's II. Quarter Income $ -11 Millions Quarterly IMDX's Income Statement
IMDX's Income by Division See IMDX's Income by Division


IMDX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions -31 28 41 85 142
Y / Y Investment Growth - -32.06 % -52 % -39.92 % 236.96 %
Net Income in Millions -50 -61 -29 -73 -64
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -219.11 % -70.18 % -86.12 % -45.17 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMDX's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMDX's Competitors
Subscribers only: Roi for Insight Molecular Diagnostics Inc's Suppliers
Subscribers only: Return On Investment for IMDX's Customers

Other Ratios
IMDX's Roa IMDX's Inventory Turnover Ratio IMDX's Growth Rates IMDX's Dividend Statistics
IMDX's Profitability Ratios IMDX's Asset Turnover Ratio IMDX's Dividend Growth
IMDX's Roe IMDX's Valuation Ratios IMDX's Financial Strength Ratios IMDX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-12T20:15:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.